Jane Street
MRNA icon

Jane Street’s Moderna MRNA Stock Holding History

Jane Street’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45M Buy
49,275
+9,812
+25% +$508K ﹤0.01% 4266
2026
Q1 		$2M Buy
39,463
+17,235
+78% +$804K ﹤0.01% 5091
2025
Q4 		$656K Sell
22,228
-1,356,964
-98% -$36.9M ﹤0.01% 7108
2025
Q3 		$35.6M Sell
1,379,192
-2,402,567
-64% -$67M 0.01% 1155
2025
Q2 		$104M Buy
3,781,759
+193,722
+5% +$5.1M 0.02% 449
2025
Q1 		$102M Sell
3,588,037
-27,023
-0.7% -$959K 0.03% 372
2024
Q4 		$150M Buy
3,615,060
+2,984,881
+474% +$143M 0.03% 315
2024
Q3 		$42.1M Sell
630,179
-684,320
-52% -$62.8M 0.01% 773
2024
Q2 		$156M Buy
1,314,499
+820,909
+166% +$104M 0.04% 263
2024
Q1 		$52.6M Sell
493,590
-202,428
-29% -$20.4M 0.01% 607
2023
Q4 		$69.2M Buy
696,018
+334,530
+93% +$28.1M 0.02% 537
2023
Q3 		$37.3M Buy
361,488
+48,698
+16% +$5.43M 0.01% 700
2023
Q2 		$38M Sell
312,790
-744,200
-70% -$99.3M 0.01% 738
2023
Q1 		$162M Buy
1,056,990
+464,961
+79% +$76.7M 0.07% 176
2022
Q4 		$106M Buy
592,029
+85,189
+17% +$13.9M 0.05% 282
2022
Q3 		$59.9M Buy
506,840
+111,046
+28% +$16.8M 0.03% 446
2022
Q2 		$56.5M Sell
395,794
-247,545
-38% -$35.4M 0.02% 505
2022
Q1 		$111M Sell
643,339
-696,531
-52% -$117M 0.04% 347
2021
Q4 		$340M Buy
1,339,870
+879,448
+191% +$257M 0.11% 100
2021
Q3 		$177M Sell
460,422
-434,998
-49% -$160M 0.06% 199
2021
Q2 		$210M Buy
895,420
+633,932
+242% +$113M 0.08% 160
2021
Q1 		$34.2M Sell
261,488
-522,079
-67% -$75.7M 0.02% 631
2020
Q4 		$81.9M Sell
783,567
-672,772
-46% -$68.1M 0.04% 303
2020
Q3 		$103M Buy
1,456,339
+270,147
+23% +$18.8M 0.06% 212
2020
Q2 		$76.2M Buy
1,186,192
+1,151,727
+3,342% +$63.1M 0.06% 235
2020
Q1 		$1.03M Sell
34,465
-27,989
-45% -$644K ﹤0.01% 2757
2019
Q4 		$1.22M Buy
+62,454
New +$1.11M ﹤0.01% 2512
2019
Q1 		– Sell
-12,390
Closed -$189K – 5395
2018
Q4 		$189K Buy
+12,390
New +$204K ﹤0.01% 4496

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Jane Street's MRNA Position: Q2 2026 in Review

Jane Street increased its Moderna (MRNA) stake by 25% in Q2 2026, buying an estimated $508K and bringing the position to 49,275 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #4266.

Jane Street first reported a position in MRNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $340M in Q4 2021. 771 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Jane Street held 49,275 shares of Moderna worth $3.45M as of Q2 2026.
  • Jane Street bought 9,812 Moderna shares in Q2 2026, an estimated $508K.
  • Moderna made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4266 holding.
  • Jane Street first reported a position in Moderna in Q4 2018 and has held it in 28 quarters since.
  • Jane Street's Moderna position peaked at $340M in Q4 2021.
  • 771 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.